Opportunities for Bioinformatics in European Drug Discovery Markets

 

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

This research service discusses the opportunities for bioinformatics in the European drug discovery market.

Table of Contents

Opportunities for Bioinformatics in European Drug Discovery Markets, Executive SummarySummary of FindingsSummaryOpportunities for Bioinformatics in European Drug Discovery Markets, GlossaryGlossary of TermsGlossaryOpportunities for Bioinformatics in European Drug Discovery Markets, Research MethodologyMethodology AdoptedMethodologyOpportunities for Bioinformatics in European Drug Discovery Markets, Overview of Challenges Faced by the Bioinformatics IndustryChallenges Faced by the Bioinformatics IndustryChallengesOpportunities for Bioinformatics in European Drug Discovery Markets, European Bioinformatics MarketMarket OverviewOverviewSegmentationMarket SegmentMarket DriversDriversMarket RestraintsRestraintsRevenue ForecastsRevenue ForecastsGeographical TrendsGeographic TrendsCompetitive AnalysisCompetitive StructureCompany ProfilingCompany ProfilesOpportunities for Bioinformatics in European Drug Discovery Markets, Genomic MarketGenomic Market in EuropeIntroductionMarket Engineering MeasurementsRevenue ForecastsOpportunities for Bioinformatics in European Drug Discovery Markets, Proteomics MarketProteomics Market in EuropeIntroductionMarket Engineering MeasurementsRevenue ForecastsOpportunities for Bioinformatics in European Drug Discovery Markets, Information Manipulation MarketInformation Manipulation Market in EuropeIntroductionMarket Engineering MeasurementsRevenue ForecastsOpportunities for Bioinformatics in European Drug Discovery Markets, Geographic TrendsEuropean Bioinformatics MarketOverviewUK Bioinformatics MarketOverviewMarket Engineering MeasurementsRevenue ForecastsGerman Bioinformatics MarketOverviewMarket Engineering MeasurementsRevenue ForecastsFrench Bioinformatics MarketOverviewMarket Engineering MeasurementsRevenue ForecastsScandinavian Bioinformatics MarketOverviewMarket Engineering MeasurementsRevenue ForecastsBenelux Bioinformatics MarketOverviewMarket Engineering MeasurementsRevenue ForecastsOpportunities for Bioinformatics in European Drug Discovery Markets, Strategic RecommendationsRecommendationsStrategiesOpportunities for Bioinformatics in European Drug Discovery Markets, Database of Key Industry ParticipantsKey Industry ParticipantsDatabase of Key Industry ParticipantsOpportunities for Bioinformatics in European Drug Discovery Markets, AppendixDecision Support DatabaseDecision Support Database




Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.